{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:11:44Z","timestamp":1791421904590,"version":"4.3.3"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020811","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:27:35Z","timestamp":1308342455000},"page":"e20811","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies"],"prefix":"10.1371","volume":"6","author":[{"given":"Florian","family":"Naudet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sol\u00e8ne","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Falissard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy.","volume":"358","author":"EH Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis.","volume":"303","author":"JC Fournier","year":"2010","journal-title":"Jama"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.","volume":"5","author":"I Kirsch","year":"2008","journal-title":"PLoS Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing.","volume":"287","author":"BT Walsh","year":"2002","journal-title":"Jama"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1192\/bjp.bp.106.028555","article-title":"Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis.","volume":"190","author":"MA Posternak","year":"2007","journal-title":"Br J Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.","volume":"19","author":"GI Papakostas","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref7","first-page":"265","article-title":"A comparison of placebo responders and nonresponders in subgroups of depressive disorder.","volume":"20","author":"RJ Bialik","year":"1995","journal-title":"J Psychiatry Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/npp.1994.63","article-title":"Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?","volume":"11","author":"MH Trivedi","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1176\/appi.ajp.162.7.1370","article-title":"Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial.","volume":"162","author":"M Zimmerman","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1176\/appi.ajp.2008.08071027","article-title":"Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.","volume":"166","author":"SR Wisniewski","year":"2009","journal-title":"Am J Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/bmj.38398.408032.8F","article-title":"Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.","volume":"330","author":"L Wei","year":"2005","journal-title":"Bmj"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.300.13.1551","article-title":"Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis.","volume":"300","author":"F Leichsenring","year":"2008","journal-title":"Jama"},{"key":"ref13","article-title":"Drugs Information Online website."},{"key":"ref14","article-title":"Joanna Briggs Institute Reviewers&apos; Manual: 2008 edition","year":"2008"},{"key":"ref15","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2.","author":"JPT Higgins","year":"2008"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.","volume":"373","author":"A Cipriani","year":"2009","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001648-199109000-00015","article-title":"Standardized regression coefficients: a further critique and review of some alternatives.","volume":"2","author":"S Greenland","year":"1991","journal-title":"Epidemiology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a114229","article-title":"The fallacy of employing standardized regression coefficients and correlations as measures of effect.","volume":"123","author":"S Greenland","year":"1986","journal-title":"Am J Epidemiol"},{"key":"ref19","article-title":"Statistical Methods for Meta-analysis","author":"L Hedges","year":"1985"},{"key":"ref20","article-title":"Statistical analysis with missing data","year":"1987"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.","volume":"283","author":"DF Stroup","year":"2000","journal-title":"Jama"},{"key":"ref23","first-page":"69","article-title":"Early symptomatic changes in patients with major depression treated with antidepressants.","volume":"13","author":"F De Jonghe","year":"1999","journal-title":"The European journal of psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.1996.03530480039038","article-title":"Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.","volume":"275","author":"GE Simon","year":"1996","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00406-008-0849-0","article-title":"The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.","volume":"259","author":"M Bauer","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(04)16261-2","article-title":"When are observational studies as credible as randomised trials?","volume":"363","author":"JP Vandenbroucke","year":"2004","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1017\/S0266462309990821","article-title":"Relative effectiveness assessment of listed drugs (REAL): a new method for an early comparison of the effectiveness of approved health technologies.","volume":"26","author":"B Falissard","year":"2010","journal-title":"Int J Technol Assess Health Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200109203451211","article-title":"The ethics of placebo-controlled trials\u2013a middle ground.","volume":"345","author":"EJ Emanuel","year":"2001","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1176\/appi.ajp.2009.09060820","article-title":"Assuring That Double-Blind Is Blind.","volume":"167","author":"RH Perlis","year":"2010","journal-title":"Am J Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/appi.ajp.159.2.191","article-title":"A reevaluation of the exclusion criteria used in antidepressant efficacy trials.","volume":"159","author":"MA Posternak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1353\/pbm.0.0076","article-title":"Some observations on observational research.","volume":"52","author":"R Bluhm","year":"2009","journal-title":"Perspect Biol Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1602\/neurorx.1.3.341","article-title":"Observational versus experimental studies: what&apos;s the evidence for a hierarchy?","volume":"1","author":"J Concato","year":"2004","journal-title":"Neuro Rx"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(04)16926-2","article-title":"Observational versus randomised trial evidence.","volume":"364","author":"DA Lawlor","year":"2004","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4088\/JCP.09m05166blu","article-title":"Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.","volume":"71","author":"F Seemuller","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref35","article-title":"Depression: management of depression in primary and secondary care. Clinical practice guideline No 23","year":"2004"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1747-5341-3-14","article-title":"Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?","volume":"3","author":"JP Ioannidis","year":"2008","journal-title":"Philos Ethics Humanit Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7861\/clinmedicine.1-6-478","article-title":"Uses and abuses of meta-analysis.","volume":"1","author":"M Egger","year":"2001","journal-title":"Clin Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(05)70200-2","article-title":"Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?","volume":"365","author":"SG Thompson","year":"2005","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"SG Thompson","year":"2002","journal-title":"Stat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2288-8-56","article-title":"Performing meta-analysis with incomplete statistical information in clinical trials.","volume":"8","author":"J Ma","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pnpbp.2009.12.001","article-title":"Accelerating response to antidepressant treatment in depression: a review and clinical suggestions.","volume":"34","author":"S Nakajima","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2008.723","article-title":"Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects.","volume":"300","author":"JP Vandenbroucke","year":"2008","journal-title":"Jama"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T21:51:11Z","timestamp":1560289871000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020811"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020811","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,8]]}}}